203 related articles for article (PubMed ID: 34398362)
41. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
42. Clinical potential of miR-3651 as a novel prognostic biomarker for esophageal squamous cell cancer.
Wang C; Guan S; Chen X; Liu B; Liu F; Han L; Un Nesa E; Song Q; Bao C; Wang X; Cheng Y
Biochem Biophys Res Commun; 2015 Sep; 465(1):30-4. PubMed ID: 26210449
[TBL] [Abstract][Full Text] [Related]
43. Association of decreased expression of long non-coding RNA LOC285194 with chemoradiotherapy resistance and poor prognosis in esophageal squamous cell carcinoma.
Tong YS; Zhou XL; Wang XW; Wu QQ; Yang TX; Lv J; Yang JS; Zhu B; Cao XF
J Transl Med; 2014 Aug; 12():233. PubMed ID: 25169763
[TBL] [Abstract][Full Text] [Related]
44. Overexpression of JAB1 promotes malignant behavior and predicts poor prognosis in esophageal squamous cell carcinoma.
Shen Q; Shang B; Jiang B; Wang Y; Wang Z; Chen G
Thorac Cancer; 2020 Apr; 11(4):973-982. PubMed ID: 32064781
[TBL] [Abstract][Full Text] [Related]
45. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
Wang WT; Guo CQ; Cui GH; Zhao S
World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
[TBL] [Abstract][Full Text] [Related]
46. Overexpression of transient receptor potential vanilloid 2 is associated with poor prognosis in patients with esophageal squamous cell carcinoma.
Zhou K; Zhang SS; Yan Y; Zhao S
Med Oncol; 2014 Jul; 31(7):17. PubMed ID: 24878697
[TBL] [Abstract][Full Text] [Related]
47. High FN1 expression is associated with poor survival in esophageal squamous cell carcinoma.
Ma J; Chen S; Su M; Wang W
Medicine (Baltimore); 2023 Apr; 102(14):e33388. PubMed ID: 37026938
[TBL] [Abstract][Full Text] [Related]
48. Clinical significance of microRNA-34a in esophageal squamous cell carcinoma.
Lin X; Xu XY; Chen QS; Huang C
Genet Mol Res; 2015 Dec; 14(4):17684-91. PubMed ID: 26782413
[TBL] [Abstract][Full Text] [Related]
49. Metformin-Induced Heat Shock Protein Family A Member 6 Is a Promising Biomarker of Esophageal Squamous Cell Carcinoma.
Sekino N; Kano M; Kobayashi S; Murakami K; Sakata H; Toyozumi T; Endo S; Matsumoto Y; Suito H; Takahashi M; Otsuka R; Yokoyama M; Shiraishi T; Okada K; Kamata T; Ryuzaki T; Hirasawa S; Kinoshita K; Sasaki T; Iida K; Komatsu A; Matsubara H
Oncology; 2022; 100(5):267-277. PubMed ID: 35134807
[TBL] [Abstract][Full Text] [Related]
50. Overexpression of UBE2C in esophageal squamous cell carcinoma tissues and molecular analysis.
Li R; Pang XF; Huang ZG; Yang LH; Peng ZG; Ma J; He RQ
BMC Cancer; 2021 Sep; 21(1):996. PubMed ID: 34488675
[TBL] [Abstract][Full Text] [Related]
51. Low GSTM3 expression is associated with poor disease-free survival in resected esophageal squamous cell carcinoma.
Yang F; Wen J; Luo K; Fu J
Diagn Pathol; 2021 Jan; 16(1):10. PubMed ID: 33482859
[TBL] [Abstract][Full Text] [Related]
52. Upregulation of the long noncoding RNA FOXD2-AS1 predicts poor prognosis in esophageal squamous cell carcinoma.
Bao J; Zhou C; Zhang J; Mo J; Ye Q; He J; Diao J
Cancer Biomark; 2018 Feb; 21(3):527-533. PubMed ID: 29286915
[TBL] [Abstract][Full Text] [Related]
53. The Role of
Xu X; Yang X; Liu X; Bi Y; Kong P; Wang Y; Cheng X; Xi Y
Technol Cancer Res Treat; 2022; 21():15330338221083105. PubMed ID: 35244467
[No Abstract] [Full Text] [Related]
54. Integrated analysis highlights multiple long non‑coding RNAs and their potential roles in the progression of human esophageal squamous cell carcinoma.
Li CY; Zhang WW; Xiang JL; Wang XH; Wang JL; Li J
Oncol Rep; 2019 Dec; 42(6):2583-2599. PubMed ID: 31638253
[TBL] [Abstract][Full Text] [Related]
55. Expression and prognostic significance of long noncoding RNA AK001796 in esophageal squamous cell carcinoma.
Zong MZ; Shao Q; An XS
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):181-186. PubMed ID: 30657559
[TBL] [Abstract][Full Text] [Related]
56. PRAF2 overexpression predicts poor prognosis and promotes tumorigenesis in esophageal squamous cell carcinoma.
Qian Z; Wei B; Zhou Y; Wang Q; Wang J; Sun Y; Gao Y; Chen X
BMC Cancer; 2019 Jun; 19(1):585. PubMed ID: 31200670
[TBL] [Abstract][Full Text] [Related]
57. Long noncoding RNA lnc-ABCA12-3 promotes cell migration, invasion, and proliferation by regulating fibronectin 1 in esophageal squamous cell carcinoma.
Ma J; Xiao Y; Tian B; Chen S; Zhang B; Wu J; Wu Z; Li X; Tang J; Yang D; Zhou Y; Wang H; Su M; Wang W
J Cell Biochem; 2020 Feb; 121(2):1374-1387. PubMed ID: 31512786
[TBL] [Abstract][Full Text] [Related]
58. Prognostic significance of Ku80 in pT2N0M0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy.
Wang S; Wang Z; Liu X; Yang Y; Shi M; Sun Z
Tumour Biol; 2015 Aug; 36(8):6181-9. PubMed ID: 25758053
[TBL] [Abstract][Full Text] [Related]
59. Loss of Protein Tyrosine Phosphatase Receptor J Expression Predicts an Aggressive Clinical Course in Patients with Esophageal Squamous Cell Carcinoma.
Qiao D; Li M; Pu J; Wang W; Zhu W; Liu H
Pathol Oncol Res; 2016 Jul; 22(3):541-7. PubMed ID: 26694178
[TBL] [Abstract][Full Text] [Related]
60. Clinical Significance and Prognostic Value of the Expression of LAG-3 and FGL1 in Esophageal Squamous Cell Carcinoma.
Yao XM; Zhang FH; Liu Y
Bull Exp Biol Med; 2023 Apr; 174(6):774-778. PubMed ID: 37162630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
